Education. Empowerment. Natural Relief.
About Us |  Contact Us |  FAQs
We're here to help. Call: 1-800-731-6327
 
PMDD Causes

PMDD Causes—Reference

  • Pinkerton JV, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol. 2010;202:221-231. http://www.ncbi.nlm.nih.gov/pubmed/20207238 (accessed 05/02/2011)
  • Tamagno G. Are changes of prolactin levels the effectors of vitex agnus castus beneficial effects on the pre-menstrual syndrome? Maturitas. 2009;63:369. http://www.ncbi.nlm.nih.gov/pubmed/19269753 (accessed 05/02/2011)
  • Huo L, Straub RE, Roca C, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry. 2007;62:925-933. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762203/?tool=pubmed (accessed 04/27/2011)
  • Dhingra V, Magnay JL, O'Brien PM, Chapman G, Fryer AA, Ismail KM. Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstet Gynecol. 2007;110:788-792. http://www.ncbi.nlm.nih.gov/pubmed/17906010 (accessed 05/02/2011)
  • Folger SG, Marchbanks PA, McDonald JA, et al. Risk of breast cancer associated with short-term use of oral contraceptives. Cancer Causes Control. 2007;18:189-198. http://www.ncbi.nlm.nih.gov/pubmed/17216547 (accessed 05/02/2011)
  • Di Giulio G, Reissing ED. Premenstrual dysphoric disorder: prevalence, diagnostic considerations, and controversies. J Psychosom Obstet Gynaecol. 2006;27:201-210. http://www.ncbi.nlm.nih.gov/pubmed/17225621 (accessed 05/02/2011)
  • Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009;195:211-217. http://bjp.rcpsych.org/cgi/content/full/195/3/211 (accessed 05/02/2011)
  • Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LT. Road traffic accidents and psychotropic medication use in the Netherlands: A case-control study. Br J Clin Pharmacol. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21501214 (accessed 05/02/2011)
  • Marv├ín ML, Escobedo C. Premenstrual symptomatology: role of prior knowledge about premenstrual syndrome. Psychosom Med. 1999;61:163-167. http://www.psychosomaticmedicine.org/content/61/2/163.long (accessed 05/02/2011)
  • Vigod SN, Ross LE, Steiner M. Understanding and treating premenstrual dysphoric disorder: an update for the women's health practitioner. Obstet Gynecol Clin North Am. 2009;36:907-24, xii. http://www.ncbi.nlm.nih.gov/pubmed/19944308 (accessed 04/02/2011)
  • Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol. 2003;18:191-195. http://www.ncbi.nlm.nih.gov/pubmed/12672170 (accessed 05/02/2011)

Last Modified: April 3, 2014

Back to: PMDD Causes

DISCLAIMER

The information and contents contained in this Web site has not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. If you are pregnant, intend to become pregnant, or nursing, please consult a physician before taking any dietary supplement. If taking prescription drugs, consult your healthcare practitioner prior to use. You must be 18 years or older to purchase products. Individual results do vary.

PMS & PMDD Stories

"I can just enjoy my life."

Amy's PMS Cramps lasted two or three weeks out of every month and took a real toll on her social life. Now she feels free. [more]

PMS Comfort Blog

Another Flawed Supplement Study Asks The Wrong Question

October 12, 2011

All multivitamins are not created equal, and most of the multivitamins that women purchase are mass-produced at the lowest possible quality with little regard for optimal health. [more]

 
Contact Us
We're here to help

1-800-731-6327